Brief: Theseus Pharmaceuticals Says Terminated Employment Of William Shakespeare As President Of Research And Development As Part Of Workforce Reduction
13/11/2023 22:12
Nov 13 (Reuters) - Theseus Pharmaceuticals Inc THRX.O :
* THESEUS PHARMACEUTICALS INC - REDUCTION OF WORKFORCE IS
EXPECTED TO RESULT IN $5.5 MILLION IN SEVERANCE COSTS
* THESEUS PHARMACEUTICALS: PART OF WORKFORCE REDUCTION
TERMINATED
EMPLOYMENT OF WILLIAM C. SHAKESPEARE, AS PRESIDENT OF RESEARCH
AND DEVELOPMENT OF CO, EFFECTIVE NOV 9
Further company coverage: THRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7